Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
与 BRACETD 一线疗法相比,接受那他珠单抗疾病修饰疗法治疗的多发性硬化症患者的长期临床疗效
期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864231221331
Butzkueven, Helmut; Kalincik, Tomas; Patti, Francesco; Slee, Mark; Weinstock-Guttman, Bianca; Buzzard, Katherine; Skibina, Olga; Alroughani, Raed; Prat, Alexandre; Girard, Marc; Horakova, Dana; Havrdova, Eva Kubala; Van der Walt, Anneke; Eichau, Sara; Hyde, Robert; Campbell, Nolan; Bodhinathan, Karthik; Spelman, Tim